![Pharmaceuticals & Biotechnology | Pharma & Biotech Resources show](https://d3dthqtvwic6y7.cloudfront.net/podcast-covers/000/037/269/small/pharmaceuticals-biotechnology-pharma-biotech-resources.jpg)
Summary: In this Pharma IQ interview Nabil Al-Tawil, Principal Investigator of the Phase I Unit at Karolinska University Hospital, speaks to Dr. Gabriele Dallmann, CEO of Pharmatching GmbH, about innovation in phase 1 clinical development. Al-Tawil explains the importance of benchmarking the